• Serialization/Track and Trace
  • Careers
  • Anti-Capital Punishment Statement
  • Contact Us
  • Online Ordering Portal
  • zoledronicpremix.com
  • glydo.com
Sagent PharmaceuticalsSagent Pharmaceuticals
Sagent Pharmaceuticals
  • Home
  • About
    • Our Executive Team
    • Who We Are
    • What We Do
    • Why We Do It
  • Products
  • PreventIV Measures®
Home > NAFCILLIN for Injection, USP Recall Information

Sagent

1.NAFCILLIN for Injection, USP Recall Information
2.LEVETIRACETAM Injection, USP Recall Information
3.PHENYLEPHRINE HCl Injection, USP Recall Information
4.We’re thrilled to keep in touch
5.Anti-Capital Punishment Statement
6.Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction
7.OXACILLIN for Injection, USP Recall Information
8.OXACILLIN for Injection, USP Recall Information
9.FLUCONAZOLE Injection, USP in 0.9% Sodium Chloride Recall Information
Total 9 result(s) found. Search for [] with Google
www.SagentPharma.com Site Map Privacy Terms of Use for Site(s) Sales Terms & Conditions

The SAGENT logo, SAGENT, SAGENT Pharmaceuticals and PreventIV Measures are registered trademarks of Sagent Pharmaceuticals.
© 2023 Sagent Pharmaceuticals